Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial.
Saved in:
| Title: | Risankizumab versus Deucravacitinib in Adults With Moderate Plaque Psoriasis: 16-Week Results from the Phase 4 IMMpactful Trial. |
|---|---|
| Authors: | Magnolo N; Department of Dermatology, University Hospital Muenster, Von-Esmarch-Str. 58, 48149, Münster, Germany. nina.magnolo@ukmuenster.de., Soung J; Department of Dermatology, Southern California Dermatology, Santa Ana, CA, USA.; Division of Dermatology, Harbor University of California Los Angeles, Torrance, CA, USA., Frew J; The Skin Hospital, Sydney, NSW, Australia.; Department of Dermatology, Liverpool Hospital, Sydney, NSW, Australia.; University of New South Wales, Sydney, NSW, Australia., Costanzo A; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Humanitas Clinical and Research Center, Scientific Institute for Research, Hospitalization and Healthcare, Rozzano, Italy., Ruiz-Santiago H; Department of Dermatology, University of Puerto Rico School of Medicine, San Juan, Puerto Rico., Eyerich K; Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany., Llamas-Velasco M; Dermatology Department, Hospital Universitario de La Princesa, Madrid, Spain., Bukhalo M; Arlington Dermatology, Ascension St. Alexius Medical Center, Hoffman Estates, IL, USA., Sivamani RK; Integrative Skin Science and Research, Sacramento, CA, USA., Moore A; Baylor University Medical Center, Dallas, TX, USA.; Arlington Research Center, Arlington, TX, USA.; Arlington Center for Dermatology, Arlington, TX, USA., Wu T; AbbVie Inc., North Chicago, IL, USA., Xie J; AbbVie Inc., North Chicago, IL, USA., Patel M; AbbVie Inc., North Chicago, IL, USA., Ashley D; AbbVie Inc., North Chicago, IL, USA., Kaplan B; AbbVie Inc., North Chicago, IL, USA., Stakias V; AbbVie Inc., North Chicago, IL, USA., Espaillat R; AbbVie Inc., North Chicago, IL, USA., Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust & Division of Musculoskeletal and Dermatological Sciences, Manchester NIHR Biomedical Research Centre, Manchester Academic Health Science Centre, University of Manchester, Machester, UK. |
| Source: | Dermatology and therapy [Dermatol Ther (Heidelb)] 2026 Jul; Vol. 16 (7), pp. 3415-3429. Date of Electronic Publication: 2026 May 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Healthcare Communications Country of Publication: Switzerland NLM ID: 101590450 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8210 (Print) NLM ISO Abbreviation: Dermatol Ther (Heidelb) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8210 |
|---|---|
| DOI: | 10.1007/s13555-026-01779-x |
